Sign up


Match Document Document Title
US20120009133 POLY (NON-CONJUGATED DIENE) BASED SUNSCREENS  
A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains...
US20130096322 METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF RECYCLED OIL, GREASE, AND FAT ORIGIN  
A method of production of value-added, biobased chemicals, derivative products, and/or purified glycerin from bioglycerin of recycled oil, grease, and/or fat origin is described herein. A method of...
US20120220655 CRYSTALLINE FORMS OF FESOTERODINE FUMARATE AND FESOTERODINE BASE  
Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized.
US20120282200 UV ABSORBING DENTRITIC POLYETHER PREPARED BY POLYMERIZATION OF OXETANES  
The present invention relates to a polymer comprising a hyperbranched dendritic polyether backbone covalently bonded via an oxygen bridge to at least one UV absorbing chromophore characterized in...
US20110020424 USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS  
The invention provides oleocanthal analogs and methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools...
US20130142834 LOCAL DELIVERY OF DRUGS FROM SELF ASSEMBLED COATINGS  
The invention relates to oligofluorinated coatings and their use in drag delivery The oligofluorinated coatings are compositions comprising formula (XVII). These coatings are used in a method of...
US20120219538 STABILIZED PROTEIN FORMULATIONS AND USE THEREOF  
The present invention is directed to stable protein formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing therapeutic proteins in aqueous...
US20130072559 RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS  
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided.
US20110086818 METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS  
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while...
US20110301288 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS  
The present invention relates to thioic acids according to formula (II) suitable as building block for polythioesters; Wherein X is O, N or S and whereby R1 is chosen from (—CH2—)2, —CH...
US20130184487 Method to produce a stable dry ionic-bonded creatine alpha ketoglutarate of high oral absorbability  
The invention provides a method to produce a stable, ionic-bonded, dry creatine-α-ketoglutarate product at a molar ratio of about 2:1. The product is stable at room temperature when kept dry for ...
US20080188556 Water-Soluble Prodrugs of Florfenicol and its Analogs  
The present invention discloses certain novel prodrugs of florfenicol and/or of florfenicol analogs, including prodrugs of salts pharmaceutically acceptable salts of florfenicol and its analogs,...
US20080139831 Water Tolerant Emulsion Stabilizers  
An emulsion stabilizer is disclosed having a water tolerance value of between more than about 1.0 and equal or less than about 11.0.
US20140179723 LOCAL COCHLEAR APPLICATION OF STATINS FOR STIMULATING NEURITE REGROWTH IN THE COCHLEA  
Statin compositions are disclosed for stimulating neurite growth from spiral ganglion neurons in the inner ear and methods for preventing damage to or treating damage of auditory neurons and/or...
US20140364604 METHOD OF MAKING MONOMETHYL FUMARATE  
Methods of making monomethyl fumarate, which can then also be used in methods of making prodrugs of monomethyl fumarate, are disclosed. Monomethyl fumarate and prodrugs of monomethyl fumarate are...
US20110110914 METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS  
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.
US20120178704 PREVENTION AND TREATMENT OF COLON CANCER  
Stilbene compounds for the prevention and treatment of colon cancer or colon inflammation and methods of using same are provided.
US20110147986 Oxygen Resistant Organic Peroxides for Reticulation/Cure and Their Use in the Process of Continuous Vulcanization in Hot Air Tunnel  
This application refers to Organic Peroxides of the Dialcyl, Perester, Perketal, and Dialkyl classes, which were modified to resist to oxygen, destined to be used in the process of production of...
US20120148690 SKIN BARRIER FUNCTION RECOVERY ACCELERATOR  
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist...
US20100307378 CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS  
The present invention relates, generally, to monomers containing carbamate-methacrylates or derivatives of carbamate-methacrylates, processes for making the monomers, and compositions comprising...
US20120108844 METHOD OF MEASURING ENTRY OF WATER INTO PHOSGENE-CONDUCTING PLANTS  
The invention relates to a method of measuring entry of water and resulting corrosion in plants for producing isocyanates by reacting phosgene with one or more primary amines in a solvent. The...
US20100092420 Preservative Systems Comprising Cationic Surfactants  
Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride...
US20110319516 RELEASE AGENT PARTITION CONTROL IN IMPRINT LITHOGRAPHY  
Release agents with increased affinity toward nano-imprint lithography template surfaces interact strongly with the template during separation of the template from the solidified resist in a...
US20110020251 Ultraviolet-Absorbing Compounds  
Disclosed are novel ultraviolet-absorbing compounds produced by two embodiments. By a first embodiment, the ultraviolet-absorbing compound is derived from at a first reactant being a UV absorber...
US20120156255 DRUG ELUTING PATCH FOR THE TREATMENT OF LOCALIZED TISSUE DISEASE OR DEFECT  
A polymeric matrix for delivery of an HMG CoA reductase inhibitor such as a statin to tissue such as cardiac tissue in need thereof for the treatment or prevention of a disease or defect such as...
US20130338089 METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS  
This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for...
US20120252892 METHODS FOR TREATING FIBROMYALGIA SYNDROME  
The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically...
US20140243411 TOPICAL DTPA PRODRUG FORMULATIONS AND METHODS OF USING THE SAME  
The present invention relates to topical trisodium diethylenetriamine pentaacetic acid (DTPA) prodrug formulations and methods of using the same.
US20120101087 Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins  
The present invention relates to, in part, novel bisphenol compounds useful for the recognition, attachment and growth of unwanted biologics on natural and manmade surfaces. Another aspect of the...
US20130078291 BIO-ADHESIVE AGENT COMPRISING SURFACE-MODIFIED HYDROXYAPATITE AND USE THEREOF  
The present invention relates to a bio-adhesive agent comprising a surface-modified hydroxyapatite and its use. More specifically, the present invention relates to a bio-adhesive agent for the...
US20110190251 METHOD FOR INHIBITING THE BUILD-UP OF ARTERIAL PLAQUE BY ADMINISTERING FULLERENES  
Disclosed herein are methods of inhibiting the build-up of arterial plaque in a subject in need thereof. These methods comprise administering to the subject in need thereof a therapeutically...
US20120000603 ADHESIVE  
The invention relates to the use of special isocyanate-terminated polyurethane prepolymers in adhesive formulations. Said adhesive formulations can be used in applications wherein a direct or...
US20110105608 MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING  
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling,...
US20130261133 Therapeutic Compounds for Protozoal and Microbial Infections and Cancer  
The compounds of the invention exhibit antiprotozoal, antimicrobial, and anticancer properties that are useful for the treatment or prevention of infections or cancer in a patient (e.g., a human)....
US20110091404 COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE  
The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and...
US20140296241 THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN  
The disclosure provides pharmaceutical preparations containing (2R,6R)-hydroxynorketamine, or (R)- or (S)-dehydronorketamine, or other stereoisomeric dehydro or hydroxylated ketamine metabolite....
US20140242606 PROBE FOR iFRET AND USE THEREOF  
The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for...
US20140188227 Fibrous Scaffold for Use in Soft Tissue Engineering  
The present invention relates to a fibrous scaffold for use as a substrate in soft tissue applications, in particular for preparing annulus fibrosus (AF) tissue. In aspects, the present invention...
US20140322810 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES  
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,...
US20140199378 NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES  
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,...
US20110269689 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS  
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs...
US20120088782 LPA RECEPTOR ANTAGONIST  
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence...
US20120142958 CHEMICAL RECYCLING OF PLA BY HYDROLYSIS  
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis...
US20140212980 HYDROPHILIC THIOL PROBE  
The present invention provides a probe that further promotes ionization in proteomic analysis using mass spectrometry, and a high-sensitive mass spectrometry method for a protein using such a...
US20110028522 FULLERENE THERAPIES FOR INFLAMMATION  
Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified...
US20130261094 TUNABLE, BIODEGRADABLE LINKER MOLECULES FOR TRANSIENT CONJUGATION OF COMPONENTS IN DRUG DELIVERY SYSTEMS, AND DRUG DELIVERY SYSTEMS PREPARED THEREWITH  
The present invention relates to a particular class of biodegradable linkers, ensuring transiently stable conjugation of building blocks and/or bioactive compounds into drug delivery systems (DDS),...
US20120302637 Methods of Treating Tachycardia and/or Controlling Heart Rate While Minimizing and/or Controlling Hypotension  
A method of treating tachycardia while minimizing and/or controlling hypotension associated with such treatment includes administering a therapeutically effective amount of a pharmaceutical...
US20120142531 Coated Dehydrated Microorganisms with Enhanced Stability and Viability  
The present invention relates to coated dehydrated microorganisms comprising a dehydrated microorganism surrounded by at least one coating, said coating comprising by dry weight at least 25% of...
US20110118686 SUBSTRATE WITH ADHERENCE FOR FECES AND MENSES  
A composition applied on the body facing surface of an absorbent article such as a diaper, training pant, adult incontinence product, feminine hygiene product, may be used to impart the adherence...
US20110319558 METHOD FOR COATING A FLOOR  
A method for coating a floor, wherein said method comprises applying an aqueous dispersion comprising polyurethane, an acrylate or a hybride or mixture thereof; drying said coating and subjecting...